Immunovant, Inc. (IMVT) has 20 已知的内部人和机构持有人记录. 最大持有人为 Roivant Sciences Ltd. 持有 113,317,007 股. 其他重要持有人包括 Health Sciences Holdings, LLC 和 Salzmann Peter.
过去12个月，内部人进行了 30 笔交易，涉及 IMVT 股票 — 5 笔买入 (价值为 $353.18M) 和 21 笔卖出 (价值为 $937.25K). 内部人卖出超过买入.
IMVT 內部人持股
最大持股人
Roivant Sciences Ltd.
113,317,007 股
主要內部人持股
| # |
姓名 |
职位 |
持股数量 |
最近申报日期 |
相对规模 |
| 1 |
Roivant Sciences Ltd. |
10 Percent Owner |
113,317,007 |
2025-12-12 |
|
| 2 |
Health Sciences Holdings, Llc |
10 Percent Owner |
10,000,000 |
2019-05-15 |
|
| 3 |
Salzmann Peter |
Chief Executive Officer |
1,178,191 |
2025-04-17 |
|
| 4 |
Wong Roderick |
Chief Executive Officer |
902,498 |
2019-12-13 |
|
| 5 |
Butchko Julia G. |
Chief Development Officer |
440,959 |
2024-08-23 |
|
| 6 |
Barnett Eva Renee |
Chief Financial Officer |
396,774 |
2025-04-17 |
|
| 7 |
Zeldin Robert K |
Chief Medical Officer |
380,325 |
2019-12-20 |
|
| 8 |
Macias William L. |
Chief Medical Officer |
357,353 |
2025-02-21 |
|
| 9 |
Levine Mark S. |
Chief Legal Officer |
319,228 |
2024-11-22 |
|
| 10 |
Geffner Michael |
Chief Medical Officer |
217,958 |
2025-10-24 |
|
| 11 |
Girao Tiago |
Chief Financial Officer |
208,388 |
2025-05-05 |
|
| 12 |
Stout Jay S |
Chief Technology Officer |
197,634 |
2026-01-23 |
|
| 13 |
Gloria Melanie |
Chief Operating Officer |
170,273 |
2026-02-27 |
|
| 14 |
Van Tuyl Christopher |
Chief Legal Officer |
147,053 |
2026-03-20 |
|
| 15 |
Middlekauff W Bradford |
General Counsel |
142,600 |
2020-05-18 |
|
| 16 |
Hughes Douglas J. |
Director |
120,773 |
2025-12-03 |
|
| 17 |
Jain Rita |
Chief Medical Officer |
117,600 |
2021-03-31 |
|
| 18 |
Elliott Michael James |
Chief Scientific Officer |
97,600 |
2021-03-23 |
|
| 19 |
Torti Frank |
Director |
93,599 |
2025-04-03 |
|
| 20 |
Fromkin Andrew J. |
Director |
85,852 |
2025-12-03 |
|
近期交易 (过去12个月)
| 日期 |
姓名 |
职位 |
类型 |
股数 |
股价 |
总价值 |
| 2026-04-02 |
Venker Eric |
Chief Executive Officer |
知情卖出 |
1,409 |
$24.60 |
$34.66K |
| 2026-04-01 |
Venker Eric |
Chief Executive Officer |
股份退回 |
334,960 |
$25.10 |
$8.41M |
| 2026-03-18 |
Van Tuyl Christopher |
Chief Legal Officer |
知情卖出 |
2,877 |
$24.97 |
$71.84K |
| 2026-02-25 |
Gloria Melanie |
Chief Operating Officer |
知情卖出 |
942 |
$28.90 |
$27.22K |
| 2026-01-21 |
Stout Jay S |
Chief Technology Officer |
知情卖出 |
1,977 |
$26.03 |
$51.46K |
| 2026-01-07 |
Stout Jay S |
Chief Technology Officer |
知情卖出 |
55 |
$26.92 |
$1.48K |
| 2025-12-18 |
Van Tuyl Christopher |
Chief Legal Officer |
知情卖出 |
2,284 |
$27.38 |
$62.54K |
| 2025-12-12 |
Roivant Sciences Ltd. |
10 Percent Owner |
知情买入 |
16,666,666 |
$21.00 |
$350M |
| 2025-12-01 |
Hughes Douglas J. |
Director |
知情卖出 |
1,909 |
$23.96 |
$45.74K |
| 2025-12-01 |
Fromkin Andrew J. |
Director |
知情卖出 |
2,898 |
$23.95 |
$69.41K |
| 2025-11-20 |
Gloria Melanie |
Chief Operating Officer |
知情卖出 |
2,375 |
$23.97 |
$56.93K |
| 2025-10-22 |
Geffner Michael |
Chief Medical Officer |
知情卖出 |
2,595 |
$19.03 |
$49.38K |
| 2025-10-22 |
Stout Jay S |
Chief Technology Officer |
知情卖出 |
2,520 |
$19.03 |
$47.96K |
| 2025-10-08 |
Geffner Michael |
Chief Medical Officer |
知情卖出 |
1,272 |
$16.30 |
$20.73K |
| 2025-10-08 |
Stout Jay S |
Chief Technology Officer |
知情卖出 |
1,585 |
$16.30 |
$25.84K |
| 2025-07-28 |
Venker Eric |
Chief Executive Officer |
限制性股票授予 (RSU) |
189,900 |
$16.76 |
$3.18M |
| 2025-07-23 |
Geffner Michael |
Chief Medical Officer |
知情卖出 |
2,385 |
$18.15 |
$43.29K |
| 2025-07-23 |
Stout Jay S |
Chief Technology Officer |
知情卖出 |
2,805 |
$18.15 |
$50.91K |
| 2025-07-09 |
Geffner Michael |
Chief Medical Officer |
知情卖出 |
1,160 |
$17.24 |
$20K |
| 2025-07-09 |
Stout Jay S |
Chief Technology Officer |
知情卖出 |
1,519 |
$17.24 |
$26.19K |
| 2025-05-01 |
Susman Robert Graham |
Director |
限制性股票授予 (RSU) |
25,016 |
- |
- |
| 2025-05-01 |
Bauer Jake |
Director |
限制性股票授予 (RSU) |
25,016 |
- |
- |
| 2025-05-01 |
Girao Tiago |
Chief Financial Officer |
限制性股票授予 (RSU) |
208,388 |
- |
- |
| 2025-04-18 |
Susman Robert Graham |
Officer |
未知 |
- |
- |
- |
| 2025-04-18 |
Bauer Jake |
Officer |
未知 |
- |
- |
- |
